D-0502-2017 Class II Terminated
FDA drug recall D-0502-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 5, 2017 and is designated Class II. Reason for recall: Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment. The recall status is terminated (terminated Jun 29, 2018). Affected quantity: 22,915 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 8, 2017
- Initiation Date
- Jan 5, 2017
- Termination Date
- Jun 29, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,915 bottles
Product description
Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, Gujarat, India, NDC 47335-956-88.
Reason for recall
Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Code information
Lot #: JKR5219A, JKR5200A, JKR5220A, JKR5221A, JKR5222A, Exp 03/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0502-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026